Overview An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers Status: NOT_YET_RECRUITING Trial end date: 2024-08-01 Target enrollment: Participant gender: Summary This study was a single-center, randomized, open-label, two-agent, two-cycle, double-cross bioequivalence trial.Phase: PHASE1 Details Lead Sponsor: Frontier Biotechnologies Inc.